Literature DB >> 32227097

Postpartum psychiatric disorders and subsequent live birth: a population-based cohort study in Denmark.

X Liu1, O Plana-Ripoll1, K G Ingstrup1, E Agerbo1,2,3, R Skjærven4,5, T Munk-Olsen1.   

Abstract

STUDY QUESTION: Are women with a history of first-onset postpartum psychiatric disorders after their first liveborn delivery less likely to have a subsequent live birth? SUMMARY ANSWER: Women with incident postpartum psychiatric disorders are less likely to go on to have further children. WHAT IS KNOWN ALREADY: Women are particularly vulnerable to psychiatric disorders in the postpartum period. The potential effects of postpartum psychiatric disorders on the mother's future chances of live birth are so far under-researched. STUDY DESIGN, SIZE, DURATION: A population-based cohort study consisted of 414 571 women who had their first live birth during 1997-2015. We followed the women for a maximum of 19.5 years from the date of the first liveborn delivery until the next conception leading to a live birth, emigration, death, their 45th birthday or 30 June 2016, whichever occurred first. PARTICIPANTS/MATERIALS, SETTING,
METHODS: Postpartum psychiatric disorders were defined as filling a prescription for psychotropic medications or hospital contact for psychiatric disorders for the first time within 6 months postpartum. The outcome of interest was time to the next conception leading to live birth after the first liveborn delivery. Records on the death of a child were obtained through the Danish Register of Causes of Death. Cox regression was used to estimate the hazard ratios (HRs), stratified by the survival status of the first child. MAIN RESULTS AND THE ROLE OF CHANCE: Altogether, 4327 (1.0%) women experienced postpartum psychiatric disorders after their first liveborn delivery. The probability of having a subsequent live birth was 69.1% (95% CI: 67.4-70.7%) among women with, and 82.3% (95% CI: 82.1-82.4%) among those without, postpartum psychiatric disorders. Women with postpartum psychiatric disorders had a 33% reduction in the rate of having second live birth (HR = 0.67, 95% CI: 0.64-0.69), compared to women without postpartum psychiatric disorders. The association disappeared if the first child died (HR = 1.01, 95% CI: 0.85-1.20). If postpartum psychiatric disorders required hospitalisations, this was associated with a more pronounced reduction in live birth rate, irrespective of the survival status of the first child (HR = 0.54, 95% CI: 0.47-0.61 if the first child survived, and HR = 0.49, 95% CI: 0.23-1.04 if the first child died). LIMITATIONS, REASONS FOR CAUTION: The use of population-based registers allows for the inclusion of a representative cohort with almost complete follow-up. The large sample size enables us to perform detailed analyses, accounting for the survival status of the child. However, we did not have accurate information on stillbirths and miscarriages, and only pregnancies that led to live birth were included. WIDE IMPLICATIONS OF THE
FINDINGS: Our study is the first study to investigate subsequent live birth after postpartum psychiatric disorders in a large representative population. The current study indicates that postpartum psychiatric disorders have a significant impact on subsequent live birth, as women experiencing these disorders have a decreased likelihood of having more children. However, the variations in subsequent live birth rate are influenced by both the severity of the disorders and the survival status of the first-born child, indicating that both personal choices and decreased fertility may have a role in the reduced subsequent live birth rate among women with postpartum psychiatric disorders. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the Danish Council for Independent Research (DFF-5053-00156B), the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 837180, AUFF NOVA (AUFF-E 2016-9-25), iPSYCH, the Lundbeck Foundation Initiative for Integrative Psychiatric Research (R155-2014-1724), Niels Bohr Professorship Grant from the Danish National Research Foundation and the Stanley Medical Research Institute, the National Institute of Mental Health (NIMH) (R01MH104468) and Fabrikant Vilhelm Pedersen og Hustrus Legat. The authors do not declare any conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.

Entities:  

Keywords:  cohort study; live birth; postpartum; psychiatric disorders; register

Mesh:

Year:  2020        PMID: 32227097      PMCID: PMC7192534          DOI: 10.1093/humrep/deaa016

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  34 in total

1.  Danish Education Registers.

Authors:  Vibeke M Jensen; Astrid W Rasmussen
Journal:  Scand J Public Health       Date:  2011-07       Impact factor: 3.021

Review 2.  Risk of Postpartum Relapse in Bipolar Disorder and Postpartum Psychosis: A Systematic Review and Meta-Analysis.

Authors:  Richard Wesseloo; Astrid M Kamperman; Trine Munk-Olsen; Victor J M Pop; Steven A Kushner; Veerle Bergink
Journal:  Am J Psychiatry       Date:  2015-10-30       Impact factor: 18.112

3.  New parents and mental disorders: a population-based register study.

Authors:  Trine Munk-Olsen; Thomas Munk Laursen; Carsten Bøcker Pedersen; Ole Mors; Preben Bo Mortensen
Journal:  JAMA       Date:  2006-12-06       Impact factor: 56.272

4.  The Danish Psychiatric Central Research Register.

Authors:  Ole Mors; Gurli P Perto; Preben Bo Mortensen
Journal:  Scand J Public Health       Date:  2011-07       Impact factor: 3.021

Review 5.  The impact of negative childbirth experience on future reproductive decisions: A quantitative systematic review.

Authors:  Shefaly Shorey; Yen Yen Yang; Emily Ang
Journal:  J Adv Nurs       Date:  2018-02-23       Impact factor: 3.187

6.  Risk of having one lifetime pregnancy and modification by outcome of pregnancy and perinatal loss.

Authors:  Aleksandra Pirnat; Lisa A DeRoo; Rolv Skjaerven; Nils-Halvdan Morken
Journal:  Acta Obstet Gynecol Scand       Date:  2019-02-03       Impact factor: 3.636

7.  Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles.

Authors:  Bernard L Harlow; Lauren A Wise; Michael W Otto; Claudio N Soares; Lee S Cohen
Journal:  Arch Gen Psychiatry       Date:  2003-01

8.  Reproduction after the loss of a child: a population-based matched cohort study.

Authors:  O Plana-Ripoll; O Basso; K D László; J Olsen; E Parner; S Cnattingius; C Obel; J Li
Journal:  Hum Reprod       Date:  2018-08-01       Impact factor: 6.918

Review 9.  Postpartum psychiatric disorders.

Authors:  Samantha Meltzer-Brody; Louise M Howard; Veerle Bergink; Simone Vigod; Ian Jones; Trine Munk-Olsen; Simone Honikman; Jeannette Milgrom
Journal:  Nat Rev Dis Primers       Date:  2018-04-26       Impact factor: 52.329

Review 10.  The Danish National Patient Registry: a review of content, data quality, and research potential.

Authors:  Morten Schmidt; Sigrun Alba Johannesdottir Schmidt; Jakob Lynge Sandegaard; Vera Ehrenstein; Lars Pedersen; Henrik Toft Sørensen
Journal:  Clin Epidemiol       Date:  2015-11-17       Impact factor: 4.790

View more
  2 in total

Review 1.  Postpartum Relapse in Patients with Bipolar Disorder.

Authors:  Javier Conejo-Galindo; Alejandro Sanz-Giancola; Miguel Ángel Álvarez-Mon; Miguel Á Ortega; Luis Gutiérrez-Rojas; Guillermo Lahera
Journal:  J Clin Med       Date:  2022-07-08       Impact factor: 4.964

2.  Adapting an intervention of brief problem-solving therapy to improve the health of women with antenatal depressive symptoms in primary healthcare in rural Ethiopia.

Authors:  Tesera Bitew; Roxanne Keynejad; Bronwyn Myers; Simone Honikman; Katherine Sorsdahl; Charlotte Hanlon
Journal:  Pilot Feasibility Stud       Date:  2022-09-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.